VEGF and Intraocular Neovascularization: From Discovery to Therapy

被引：77
|
作者：
Ferrara, Napoleone [1 ]
机构：
[1] Univ Calif San Diego, Med Ctr, La Jolla, CA 92093 USA
来源：
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY | 2016年 / 5卷 / 02期
关键词：
VEGF; angiogenesis; tyrosine kinase; age-related macular degeneration; antibody; ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; MACULAR DEGENERATION; TUMOR ANGIOGENESIS; TYROSINE KINASE; CHOROIDAL NEOVASCULARIZATION; RANIBIZUMAB TREATMENT; EXTRACELLULAR-MATRIX; CELLS SECRETE; BASIC SCIENCE;
D O I：
10.1167/tvst.5.2.10
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
I am honored and humbled to be one of the awardees of the 2014 A. Champalimaud Vision Award. I offer my heartfelt thanks to the Champalimaud Foundation President, Leonor Beleza, and to the Award Committee Members for this wonderful recognition. I feel especially fortunate to have had the opportunity to witness my scientific discoveries move from the bench to the clinic. Scientific discovery is hugely exciting, but the ability to translate that work into potentially helping someone lead a better life is even more fulfilling. This Award is dedicated to the patients.
引用
收藏
页数：8
相关论文
共 50 条
  • [11] Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy
    Kelvin Yi Chong Teo
    Wei Yan Ng
    Shu Yen Lee
    Chui Ming Gemmy Cheung
    [J]. Drugs, 2016, 76 : 1119 - 1133
  • [12] Anti-VEGF-B therapy in a rat model of corneal neovascularization
    Irani, Yazad
    Scotney, Pierre
    Nash, Andrew
    Klebe, Sonja
    Williams, Keryn
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [13] The Effect of Intravitreal Anti-VEGF Therapy on Intraocular Pressure
    Chu, Fred
    Kiernan, Claire
    Becker, Norbert
    Hawkins, Anjali
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [14] EXPERIMENTAL INTRAOCULAR PROLIFERATION AND NEOVASCULARIZATION
    OPHIR, A
    BLUMENKRANZ, MS
    CLAFLIN, AJ
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 94 (04) : 450 - 457
  • [15] CHEMICAL MEDIATORS OF INTRAOCULAR NEOVASCULARIZATION
    GLASER, BM
    DAMORE, PA
    LUTTY, GA
    FENSELAU, AH
    MICHELS, RG
    PATZ, A
    [J]. TRANSACTIONS OF THE OPHTHALMOLOGICAL SOCIETIES OF THE UNITED KINGDOM, 1980, 100 (SEP): : 369 - 373
  • [16] Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment
    Takahashi, K
    Saishin, Y
    Saishin, Y
    Silva, RL
    Oshima, Y
    Oshima, S
    Melia, M
    Paszkiet, B
    Zerby, D
    Kadan, MJ
    Liau, G
    Kaleko, M
    Connelly, S
    Luo, TC
    Campochiaro, PA
    [J]. FASEB JOURNAL, 2003, 17 (03): : 896 - +
  • [17] The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization
    Chen, Qin
    Yu, Xiaobing
    Sun, Zihan
    Dai, Hong
    [J]. JOURNAL OF OPHTHALMOLOGY, 2016, 2016
  • [18] AMD associated Peripapillary Choroidal Neovascularization in the era of anti-VEGF therapy
    Lin, Tiezhu
    Dans, Kunny C.
    Meshi, Amit
    Amador, Manuel
    Freeman, William R.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [19] Safety review of anti-VEGF therapy in patients with myopic choroidal neovascularization
    Ng, Danny S. C.
    Ho, Mary
    Iu, Lawrence P. L.
    Lai, Timothy Y. Y.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2022, 21 (01) : 43 - 54
  • [20] Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF
    Sharma, Rajesh K.
    Rogojina, Anna T.
    Chalam, K. V.
    [J]. MOLECULAR VISION, 2010, 16 (232-33): : 2175 - 2184
12345